Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 104 results found. Search for [ essential drugs ]

Results 20 to 40 of 104
Anand Kumar Patel
July 14, 2017
For instance, Emcure Pharmaceuticals was offering its drug Temcure 250 mg to an Amritsar-based cancer hospital at just Rs 1,950 while  patients have to pay about nine times more at  Rs 18,647.


PTI
New Delhi, June 13, 2017
The government has fixed GST rate of 12 per cent on most of the essential drugs as against the current tax incidence of around 9 per cent.


Reuters
New Delhi, June 7, 2017
India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients.


Joe C Mathew
New Delhi, May 1, 2017
Apex think tank Niti Aayog has proposed a change in the manner the government identifies medicines that should be brought under price control.


BT Online
January 19, 2017
We look at what CEOs at India Inc expect from Union Budget 2017-18 speech to be presented by Finance Minister Arun Jaitley on February 1, 2017.


By E Kumar Sharma
Delhi, November 12, 2016
Any change in the drug price control regime purely for ease of doing business can have serious ramifications.


PTI
August 29, 2016
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.


PTI
New Delhi, August 19, 2016
\"NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013,\" the National Pharmaceutical Pricing Authority (NPPA) said in a statement.


PTI
New Delhi, August 1, 2016
\"National Pharmaceutical Pricing Authority (NPPA) has fixed/revised ceiling prices of 24 scheduled formulations of schedule-I under Drugs (Price Control) Amendment Order, 2016,\" the drug pricing regulator said in a order on its website.


PTI
New Delhi, June 6, 2016
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.


Reuters
April 1, 2016
Shortages of essential drugs, mostly generic medicines whose patents have long expired, are becoming increasing frequent globally, prompting the World Health Organization (WHO) to suggest minimum prices may be needed to keep some products on the market.


Mail Today Bureau
New Delhi, April 1, 2016
As many as 103 drug formulation packs, including those used for treating bacterial infections, diabetes, high blood pressure, tuberculosis, epilepsy, Hepatitis C and HIV/AIDS, have become cheaper.


E Kumar Sharma
December 31, 2015
According to an analysis put out by the pharmaceutical market research entity AIOCD AWACS on Wednesday, the most likely to be impacted would be Cipla, Pfizer and Sun Pharma.


Joe C Mathew
December 29, 2015
While a total of 106 medicines have been added, 70 medicines have been deleted to finalise the new list.


By K. Srinath Reddy
Delhi, December 30, 2015
K. Srinath Reddy, President, Public Health Foundation of India, looks at the way ahead for universal health insurance in India.


Ajay Tyagi and Munish Shekhavat
New Delhi, December 23, 2015
Globally also, it remained a year marked with record mergers, led by the $160 billion deal between Viagra maker Pfizer Inc and Botox manufacturer Allergan.


Neetu Chandra Sharma
New Delhi, December 2, 2015
The Pharma Jan Samadhan initiative for complaint redressal system regarding availability of medicines, recorded at least 295 complaints in past eight months.


IANS
New Delhi, November 6, 2015
\"The union Cabinet, chaired by Prime Minister Narendra Modi, has approved $750-million FDI in Mylan Laboratories Ltd by Mylan Group through equity shares or convertible debentures for acquiring entire shareholding of Jai Pharma Ltd (JPL),\" an official statement said in New Delhi.


Mail Today Bureau
New Delhi, September 21, 2015
Public and private hospitals, insurance companies, pharmaceutical firms and their associations, doctors and their associations, among others, would be covered under the study.


PTI
New Delhi, August 27, 2015
In a statement, drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) said, \"It has fixed/revised the prices in respect of 39 formulation packs ... and one corrigendum ... related to the ceiling price fixation of Paclitaxel injection.\"


PAGES 2 OF 6  12345